Jul 11, 2023 | Brand Name Drugs, Generic Drugs, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings, Specialty Drugs, Transparency, Value
A new playbook from the National Alliance of Healthcare Purchaser Coalitions lists the top 10 concerns employer health plans have with pharmacy benefit managers (PBMs): Promoting drugs with higher prices when lower-price options are availableOffering preferred...
Jun 15, 2023 | Obesity, Ozempic, Pharmacy, Prescription, Rx Costs, Semaglutide, Wegovy, Weight loss
Obesity drugs are becoming big business, with a correspondingly big price tag. And with these drugs regularly making headlines, questions about whether or not health plans should cover them grow louder. The highest-profile obesity drug is semaglutide, sold under the...
May 16, 2023 | Alternative Reimbursement Strategies, Announcements, Case Studies, Client Report, Client Services, Client Surveys, Communication, Compliance, Cost Plus Pricing, Cost Savings, Direct-to-Employer Contracting, Drug costs, Forensic claims review, HealthJoy, Inflation, Kurt Harden, MedBen Rx, MedBen WellLiving, Member engagement, Mobile App, Online Services, Own Use, Pharmacy, Pharmacy Benefits Manager (PBM), Plan Design, Plan Language, Prescription, Reference-Based Pricing, Regulatory, Rx Costs, Savings, Self-funding, Specialty Drugs, Supreme Court, Wellness
The 2023 MedBen Client Report is now available to download from MedBen.com! In his opening note, MedBen President Kurt Harden states: “This Client Report is designed to demonstrate ways that clients can generate greater value from their health plan. With health...
Apr 17, 2023 | biologics, Biosimilars, Brand Name Drugs, Cost Savings, Generic Drugs, Pharmacy, Prescription, Rx Costs, Savings
Much like generics are lower-cost equivalents of more expensive drugs, so too are biosimilars. But there’s a notable distinction between the two. Generics contain the exact same active ingredients as their brand-name counterparts and are usually synthesized from...
Mar 6, 2023 | Access solutions, Cost Savings, MedBen Rx, Medicare, Research, Rx Costs, Savings, Specialty Drugs
Employers pay up to 30 times as much for specialty drugs than Medicare does, new research finds. According to the JAMA Health Forum, for the 10 most commonly used specialty drugs, employer-sponsored insurance (ESI) plans paid prices up to 3,350% higher than Medicare....
Feb 6, 2023 | Announcements, Benchmarks, Case Studies, Compliance, Direct-to-Employer Contracting, MedBen Rx, MedBen University, Roundtables, Rx Costs, Specialty Drugs, Supreme Court
The 22nd Season of MedBen University (MBU) will soon be in session! In 2023, MBU will explore current benefit management issues and proven solutions MedBen offers, including: Reducing Rx spend through alternative specialty drug funding, as well as other pharmacy plan...
